Skip to main content
. 2016 Sep 6;23(9):767–773. doi: 10.1128/CVI.00154-16

FIG 2.

FIG 2

Mild skin reactions in one subject (no. 6) in group A (subjects received 1 μg/ml of ESAT6-CFP10), who developed a 2- by 2-mm subcutaneous hemorrhage at the injection site 24 h after the skin test, which flattened at 48 and 72 h and subsided at 96 h after the skin test.